Stanley Frankel

Stanley Frankel

Company: Cytovia

Job title: Chief Medical Officer

Seminars:

Exploring the Potential of Combining Engineered iPSC NK Cells with NK cell Engagers & the Future of Cell Therapies 12:00 pm

Advantages of IPSC derived NK products vs NK cell line, donor derived, or cord blood Advantages of NK cell therapies over CAR-T cell therapies Advantages of TALEN over CRISPRRead more

day: Focus Day - Track B - Afternoon

Exploring the Potential of Combining Engineered iPSC NK Cells with NK cell Engagers and the Future of Cell Therapies 1:45 pm

• Advantages of IPSC derived NK products vs NK cell line, donor derived, or cord blood • Advantages of NK cell therapies over CAR-T cell therapies • Advantages of TALEN over CRISPRRead more

day: Day 2 - Track C - Afternoon

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.